(Q40598012)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730703%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

title

CD44-independent hepatocyte growth factor/c-Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730703%20AND%20SRC:MED&resulttype=core&format=json

malignant peripheral nerve sheath tumor

17 November 2019

main subject

0 references

adult malignant schwannoma

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730703%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

David H. Gutmann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730703%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

author name string

Weiping Su

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730703%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Roger Abounader

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730703%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

John Laterra

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730703%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Larry S Sherman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730703%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

publication date

1 February 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730703%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730703%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730703%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730703%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

page(s)

297-306

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730703%20AND%20SRC:MED&resulttype=core&format=json

Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27(kip) in malignant transformation of neurofibromas

17 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

A case of neurofibrosarcoma associated with neurofibromatosis: light microscopic, ultrastructural, immunohistochemical and biochemical investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

p53 expression in neurofibroma and malignant peripheral nerve sheath tumor. An immunohistochemical study of sporadic and NF1-associated tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Malignant peripheral nerve sheath tumours in neurofibromatosis 1

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Coexpression of HGF and c-Met/HGF receptor in human bone and soft tissue tumors.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Malignant schwannoma.A Clinicopathologic Study

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Co-operative effect of c-Src tyrosine kinase and Stat3 in activation of hepatocyte growth factor expression in mammary carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Role of Src expression and activation in human cancer

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

CD44 variant-specific antibodies trigger hemopoiesis by selective release of cytokines from bone marrow macrophages

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Hepatocyte growth factor is a mitogen for Schwann cells and is present in neurofibromas

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

p53 and Ki-67 proliferating cell nuclear antigen in benign and malignant peripheral nerve sheath tumors in children

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

CD44 is required for two consecutive steps in HGF/c-Met signaling.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

CD44: from adhesion molecules to signalling regulators

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

c-Src kinase activity is required for hepatocyte growth factor-induced motility and anchorage-independent growth of mammary carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Hepatocyte growth factor and c-MET in benign and malignant peripheral nerve sheath tumors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Neoplasms with neural differentiation: a review. Part II: Malignant neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Overexpression of activated neu/erbB2 initiates immortalization and malignant transformation of immature Schwann cells in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

CD44 enhances neuregulin signaling by Schwann cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Malignant schwannoma--clinical characteristics, survival, and response to therapy

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Malignant peripheral nerve sheath tumor cell invasion is facilitated by Src and aberrant CD44 expression

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Heparan Sulfate-modified CD44 Promotes Hepatocyte Growth Factor/Scatter Factor-induced Signal Transduction through the Receptor Tyrosine Kinase c-Met

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Malignant peripheral nerve sheath tumour arising within neurofibroma. An immunohistochemical analysis in the comparison between benign and malignant components

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Survival in malignant schwannoma.An 18-year study

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Malignant peripheral nerve sheath tumor: analysis of treatment outcome

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

HGF/SF-met signaling in the control of branching morphogenesis and invasion

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10340

7 January 2021

Identifiers

DOI

10.1002/GLIA.10340

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730703%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1 reference